Medicare rule on lowering drug prices for four companies

AI justification

[Auto-resolved by learned corrector: learned-map — A=MINT/B=NEUTRAL -> MINT (human chose this in 93% of 255 past reviews)] Limited rule weakens drug price protections, enabling continued high costs. | While the Medicare rule represents a step toward reducing drug prices, its severely diluted impact and narrow scope undermine its potential to meaningfully improve healthcare access. The action fails to address broader systemic issues, leaving significant barriers to affordable medication intact.